Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using

Introduction: Male pattern hair loss (MPHL), also known as androgenetic alopecia (AGA), is a common disorder primarily caused by dihydrotestosterone (DHT). The Food and Drug Administration (FDA) has approved two 5-alpha reductase (5-AR) inhibitors-finasteride and dutasteride-for treating this condition. However, recent studies have reported adverse sexual side effects and issues with sperm production in young men using these medications. There are also recommendations for effectively treating hair loss with natural remedies, such as Methods: For the first time, we aimed to applied a computational study to explore the phytochemicals extracted from these herbs to identify compounds that can effectively bind to and inhibit 5-AR. Additionally, we assessed the stability of the ligands encapsulated in lipid nanoparticles (LNP) by conducting molecular dynamics (MD) simulations of the LNP-encapsulated ligands. We utilized an online database to identify compounds from the extracts of nettle, saw palmetto, and fenugreek. We then analyzed their binding affinity to 5-AR using computational techniques. Results: We found that 6 molecules-Jamogenin, Neodiosgenin, Chlorogenic acid, Rutin, Riboflavin, and Ursolic acid-are effective in binding to 5-AR. Additionally, our Discussion: Therefore, these 6 molecules, particularly JAMOGENIN, should be considered for experimental analysis in both their unencapsulated and nanocarrier-encapsulated states to promote hair follicle growth.